199 related articles for article (PubMed ID: 33815659)
1. Inhibition of Inducible Nitric Oxide Synthase (iNOS) by Andrographolide and
Pasha A; Kumbhakar DV; Doneti R; Kumar K; Dharmapuri G; Poleboyina PK; S K H; Basavaraju P; Pasumarthi D; S D A; Soujanya P; Arnold Emeson I; Bodiga V; Pawar SC
Oxid Med Cell Longev; 2021; 2021():6692628. PubMed ID: 33815659
[TBL] [Abstract][Full Text] [Related]
2. Screening and Identification of Potential iNOS Inhibitors to Curtail Cervical Cancer Progression: an In Silico Drug Repurposing Approach.
Poleboyina PK; Rampogu S; Doneti R; Pasha A; Poleboyina SM; Bhanothu S; Pasumarthi D; S D A; Kumbhakar D; Lee KW; Pawar SC
Appl Biochem Biotechnol; 2022 Jan; 194(1):570-586. PubMed ID: 34705247
[TBL] [Abstract][Full Text] [Related]
3. Andrographolide suppresses the expression of inducible nitric oxide synthase in macrophage and restores the vasoconstriction in rat aorta treated with lipopolysaccharide.
Chiou WF; Lin JJ; Chen CF
Br J Pharmacol; 1998 Sep; 125(2):327-34. PubMed ID: 9786505
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of suppression of inducible nitric oxide synthase (iNOS) expression in RAW 264.7 cells by andrographolide.
Chiou WF; Chen CF; Lin JJ
Br J Pharmacol; 2000 Apr; 129(8):1553-60. PubMed ID: 10780958
[TBL] [Abstract][Full Text] [Related]
5. Function of inducible nitric oxide synthase in the regulation of cervical cancer cell proliferation and the expression of vascular endothelial growth factor.
Dong J; Cheng M; Sun H
Mol Med Rep; 2014 Feb; 9(2):583-9. PubMed ID: 24297386
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer.
Granados-Principal S; Liu Y; Guevara ML; Blanco E; Choi DS; Qian W; Patel T; Rodriguez AA; Cusimano J; Weiss HL; Zhao H; Landis MD; Dave B; Gross SS; Chang JC
Breast Cancer Res; 2015 Feb; 17(1):25. PubMed ID: 25849745
[TBL] [Abstract][Full Text] [Related]
7. Andrographolide Inhibits Proliferation of Colon Cancer SW-480 Cells
Khan I; Mahfooz S; Saeed M; Ahmad I; Ansari IA
Anticancer Agents Med Chem; 2021; 21(4):487-497. PubMed ID: 32679024
[TBL] [Abstract][Full Text] [Related]
8. Andrographolide inhibits PI3K/AKT-dependent NOX2 and iNOS expression protecting mice against hypoxia/ischemia-induced oxidative brain injury.
Chern CM; Liou KT; Wang YH; Liao JF; Yen JC; Shen YC
Planta Med; 2011 Oct; 77(15):1669-79. PubMed ID: 21512969
[TBL] [Abstract][Full Text] [Related]
9. High nitric oxide production, secondary to inducible nitric oxide synthase expression, is essential for regulation of the tumour-initiating properties of colon cancer stem cells.
Puglisi MA; Cenciarelli C; Tesori V; Cappellari M; Martini M; Di Francesco AM; Giorda E; Carsetti R; Ricci-Vitiani L; Gasbarrini A
J Pathol; 2015 Aug; 236(4):479-90. PubMed ID: 25875314
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide antagonism to glioblastoma photodynamic therapy and mitigation thereof by BET bromodomain inhibitor JQ1.
Fahey JM; Stancill JS; Smith BC; Girotti AW
J Biol Chem; 2018 Apr; 293(14):5345-5359. PubMed ID: 29440272
[TBL] [Abstract][Full Text] [Related]
11. Correlation of plasma nitrite/nitrate levels and inducible nitric oxide gene expression among women with cervical abnormalities and cancer.
Sowjanya AP; Rao M; Vedantham H; Kalpana B; Poli UR; Marks MA; Sujatha M
Nitric Oxide; 2016 Jan; 52():21-8. PubMed ID: 26435258
[TBL] [Abstract][Full Text] [Related]
12. Andrographolide protects against lipopolysaccharide-induced vascular hyporeactivity by suppressing the expression of inducible nitric oxide in periaortic adipose.
Hai-Mei L; Song-Yin H; Run-Mei L; Xiao-Huang X; Le-Quan Z; Xiao-Ping L; Jin-Wen X
J Cardiovasc Pharmacol; 2013 Aug; 62(2):154-9. PubMed ID: 23575260
[TBL] [Abstract][Full Text] [Related]
13. Andrographolide Induces G2/M Cell Cycle Arrest and Apoptosis in Human Glioblastoma DBTRG-05MG Cell Line via ERK1/2 /c-Myc/p53 Signaling Pathway.
Othman NS; Mohd Azman DK
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235222
[TBL] [Abstract][Full Text] [Related]
14. Andrographolide Inhibits Proliferation and Metastasis of SGC7901 Gastric Cancer Cells.
Dai L; Wang G; Pan W
Biomed Res Int; 2017; 2017():6242103. PubMed ID: 28194420
[TBL] [Abstract][Full Text] [Related]
15. Involvement of nitric oxide synthase in matrix metalloproteinase-9- and/or urokinase plasminogen activator receptor-mediated glioma cell migration.
Zhuang T; Chelluboina B; Ponnala S; Velpula KK; Rehman AA; Chetty C; Zakharian E; Rao JS; Veeravalli KK
BMC Cancer; 2013 Dec; 13():590. PubMed ID: 24325546
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of matrix metalloproteinases and inducible nitric oxide synthase by andrographolide in human osteoarthritic chondrocytes.
Ding QH; Ji XW; Cheng Y; Yu YQ; Qi YY; Wang XH
Mod Rheumatol; 2013 Nov; 23(6):1124-32. PubMed ID: 23242626
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity of apigenin toward multiple myeloma cell lines and suppression of iNOS and COX-2 expression in STAT1-transfected HEK293 cells.
Adham AN; Abdelfatah S; Naqishbandi AM; Mahmoud N; Efferth T
Phytomedicine; 2021 Jan; 80():153371. PubMed ID: 33070080
[TBL] [Abstract][Full Text] [Related]
18. Statin-induced breast cancer cell death: role of inducible nitric oxide and arginase-dependent pathways.
Kotamraju S; Williams CL; Kalyanaraman B
Cancer Res; 2007 Aug; 67(15):7386-94. PubMed ID: 17671209
[TBL] [Abstract][Full Text] [Related]
19. Andrographolide induces apoptosis in B16F-10 melanoma cells by inhibiting NF-κB-mediated bcl-2 activation and modulating p53-induced caspase-3 gene expression.
Pratheeshkumar P; Sheeja K; Kuttan G
Immunopharmacol Immunotoxicol; 2012 Feb; 34(1):143-51. PubMed ID: 21682651
[TBL] [Abstract][Full Text] [Related]
20. 15-Hydroxyeicosatetraenoic acid (15-HETE) protects pulmonary artery smooth muscle cells from apoptosis via inducible nitric oxide synthase (iNOS) pathway.
Nie X; Song S; Zhang L; Qiu Z; Shi S; Liu Y; Yao L; Zhu D
Prostaglandins Other Lipid Mediat; 2012 Jan; 97(1-2):50-9. PubMed ID: 22101001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
